• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

Model Number 271500
Device Problems Degraded (1153); Patient-Device Incompatibility (2682)
Patient Problems Itching Sensation (1943); Pain (1994); Burning Sensation (2146)
Event Date 05/13/2020
Event Type  Injury  
Manufacturer Narrative
Up to today, it is not proven that the clip marker leaded to this incident. The patient initially went to the clinic because of an inflammation on the breast. At this time, the clip marker was not implanted at all. Also, the other later developed symptoms could be caused by her breast cancer disease. Furthermore, a nickel allergy is not diagnosed, yet. In case that the symptoms are caused by a nickel allergy, the physician would have had applied the clip marker, ignoring the contraindications of the product. Before implanting the clip marker the patient was not asked, whether she has any allergies to nickel. In the instruction for use it is stated that the clip marker consists of nickel-titanium. The section "contraindications" contains, that "the use of the tumark® q is contraindicated in patients who suffer from a severe nickel allergy. ".
Event Description
The following information has been sent by (b)(6) to somatex medical technologies (b)(4): patient (female, (b)(6)) came (b)(6) 2020 to the clinic for tumors ( zagreb) because of inflammation on the breast. After examination with ultrasound and mammography, patient was recommended biopsy. During biopsy, markation was left in the breast without patient knowledge using tumark q. Patient was not asked if she had any allergies to ni (nitiol). Tumark q, length 12 cm, diameter 18g, ref 271500, lot 18132 was used on the patient. (b)(6) 2020 patient reports to the same clinic to pick up test results and complained to the doctor about itching and stinging feeling in the breast. Doctor assures her that it is a normal feeling because of carcinom. After sending home, patient does not feel well and takes analgetics and that afternoon due to unbearable pain and stinging reports to the emergency unit in clinic for tumors (zagreb) where she was sent away. In emergency unit in another hospital she is treated with antibiotics and again sent home. On (b)(6) 2020 patient is examined with ultrasound and color doppler in private clinic. Markation and q tip are displaced and disintegrated and on the breasts are visible bruises. There is also a danger of ni poisoning and migration of tumark markation. Patient is in life threatening situation and endures great pain.
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameTUMARK Q
Type of DeviceTUMARK Q
Manufacturer (Section D)
hohenzollerndamm 150/151
berlin, 14199
GM 14199
MDR Report Key10122071
MDR Text Key197606169
Report Number1000408433-2020-00001
Device Sequence Number1
Product Code NEU
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation
Type of Report Initial
Report Date 05/14/2020,06/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Model Number271500
Device Catalogue Number271500
Device Lot Number18132
Was Device Available for Evaluation? No
Is the Reporter a Health Professional?
Was the Report Sent to FDA? No
Distributor Facility Aware Date05/14/2020
Device Age4 MO
Event Location No Information
Date Report to Manufacturer05/14/2020
Date Manufacturer Received05/14/2020
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/15/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 06/05/2020 Patient Sequence Number: 1